Search by Drug Name or NDC

    NDC 42291-0862-60 Lacosamide 150 mg/1 Details

    Lacosamide 150 mg/1

    Lacosamide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is LACOSAMIDE.

    Product Information

    NDC 42291-0862
    Product ID 42291-862_0e9ae2d1-a9ca-d188-e063-6394a90a0213
    Associated GPIs
    GCN Sequence Number 064434
    GCN Sequence Number Description lacosamide TABLET 150 MG ORAL
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 14341
    HICL Sequence Number 035872
    HICL Sequence Number Description LACOSAMIDE
    Brand/Generic Generic
    Proprietary Name Lacosamide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lacosamide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name LACOSAMIDE
    Labeler Name AvKARE
    Pharmaceutical Class Decreased Central Nervous System Disorganized Electrical Activity [PE]
    DEA Schedule CV
    Marketing Category ANDA
    Application Number ANDA204857
    Listing Certified Through 2025-12-31

    Package

    NDC 42291-0862-60 (42291086260)

    NDC Package Code 42291-862-60
    Billing NDC 42291086260
    Package 60 TABLET in 1 BOTTLE (42291-862-60)
    Marketing Start Date 2022-06-15
    NDC Exclude Flag N
    Pricing Information N/A